Skip to main content

Table 1 Clinical and pathological data of obese breast cancer patients

From: Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity

Characteristic

Non-IBC

(N = 31)

IBC

(N = 13)

P value

Age (years)

 Range

36-71

30-69

0.656ª

 Mean ± SEM

48.5 ± 1.5

46.23 ± 4.68

Tumour size (cm)

 ≤ 4

14 (45.2%)

6 (60%)

1b

 > 4

8 (25.8%)

4 (40%)

 NA

9

3

Lymph node status, n (%)

 ≤ 4

19 (61.3%)

6 (50%)

0.29b

 > 4

8 (25.8%)

6 (50%)

 NA

4

1

Tumour grade, n (%)

 G1

0

0

0.65b

 G2

23 (74.2%)

12 (92.3%)

 G3

4 (12.9%)

1 (7.7%)

 NA

4

0

Lymphovascular invasion, n (%)

 Negative

10 (32.3%)

4 (40%)

0.7b

 Positive

9 (29%)

6 (60%)

 NA

12

3

ER, n (%)

 Negative

4 (12.9%)

2 (15.38%)

1b

 Positive

26 (83.9%)

11 (84.62%)

 NA

1

0

PR, n (%)

 Negative

5 (16.1%)

3 (23.08%)

0.68b

 Positive

25 (80.6%)

10 (76.92%)

 NA

1

0

HER-2, n (%)

 Negative

23 (74.2%)

8 (61.54%)

1b

 Positive

7 (22.6%)

5 (38.46%)

 NA

1

0

  1. Data are expressed as mean ± SEM
  2. NA not available
  3. *significant P-value calculated by ªStudent’s t-test or bPearson Chi-Square